Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Neoplasms 2Melanoma 2Thyroid Diseases 1Stomach Neoplasms 1Skin Neoplasms 1Neuroma, Acoustic 1Lung Neoplasms 1Gastrointestinal Stromal Tumors 1Gastrointestinal Diseases 1Endometrial Neoplasms 1Brain Neoplasms 1Adenolymphoma 1

Interventions

Paclitaxel 19pembrolizumab 16Carboplatin 12Bevacizumab 8lenvatinib 6rucaparib 5Nivolumab 5Megestrol Acetate 5Radiation 4Indocyanine Green 4Gemcitabine 4Cisplatin 4tisotumab vedotin 3temsirolimus 3Sirolimus 3Sentinel Lymph Node Biopsy 3Magnetic Resonance Spectroscopy 3Doxorubicin 3olaparib 2niraparib 2ixabepilone 2iso-sulfan blue 2irosustat 2epacadostat 2durvalumab 2copanlisib 2Trastuzumab 2Taxes 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Endometrial Neoplasms × Fluorescein × Clear all
NCT01979003 2022-02-24

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

University of Arkansas

Phase EARLY_PHASE1 Completed
100 enrolled 6 charts
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡